Melanocortin-4 Receptor Antagonists as Potential Therapeutics in the Treatment of Cachexia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|7|11|1131-1136

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.11, 2007-06, pp. : 1131-1136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melanocortin-4 Receptor Antagonists for the Treatment of Depression and Anxiety Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1145-1151

Bentham Science Publishers

Access to resources Recommend Favorite

The use of melanocortin antagonists in cachexia of chronic disease

By Scarlett Jarrad M   Marks Daniel L  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1233-1240

Informa Healthcare

Access to resources Recommend Favorite

Melanocortin - 4 Receptor Agonists for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1121-1130

Bentham Science Publishers

Access to resources Recommend Favorite

N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 749-770

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 207-221

Bentham Science Publishers

Access to resources Recommend Favorite